Ultraviolet-A and Riboflavin Treatment for Infectious Keratitis
Not Applicable
Completed
- Conditions
- Infectious Keratitis
- Interventions
- Other: Ultraviolet-A and riboflavin
- Registration Number
- NCT01739673
- Lead Sponsor
- Cxlusa
- Brief Summary
This study is to evaluate the efficacy of ultraviolet-A (UVA) and riboflavin application (also often referred to as corneal collagen crosslinking) as a method to enhance treatment of infectious keratitis.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 13
Inclusion Criteria
- Subjects must be 18 years of age or older.
- Ability to provide written informed consent.
- Likely to complete all study visits.
- Subjects must have one eye that with a diagnosis of infectious keratitis.
Read More
Exclusion Criteria
- A corneal perforation.
- Descemetocele.
- Pregnancy or breastfeeding.
- Active Herpes corneal disease.
- Patient is unwilling or unable to comply with a medication regimen and follow up appointments.
Read More
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Ultraviolet-A and riboflavin Ultraviolet-A and riboflavin -
- Primary Outcome Measures
Name Time Method Resolution of Signs and Symptoms of Infectious Keratitis Subjects will be followed until resolution of signs and symptoms, an expected average of 8 weeks
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (6)
Schwartz Laser Eye Center
🇺🇸Scottsdale, Arizona, United States
Corneal Consultants of Colorado, PC
🇺🇸Littleton, Colorado, United States
Minnesota Eye Consultants
🇺🇸Minneapolis, Minnesota, United States
Davidorf Eye Group
🇺🇸West Hills, California, United States
Center for Excellence in Eye Care
🇺🇸Miami, Florida, United States
Ophthalmology Associates
🇺🇸Saint Louis, Missouri, United States